SNT 25.7% 4.4¢ syntara limited

cystic fibrosis trial reaches target recruitment, page-8

  1. 487 Posts.
    lightbulb Created with Sketch. 83
    If the trials are being conducted properly, the company would have no idea of the results as they are all conducted double blind ie. the people actually conducting the trial do not know which patient is getting what. Not until all results are in are the codes deciphered. Therefore, any supposed 'good results' are either a fabrication of someone trying to ramp this stock or poor trial management and a concern for everyone as to the validity of the results. This company appears to have good management and therefore I do not believe it is the latter.
 
watchlist Created with Sketch. Add SNT (ASX) to my watchlist
(20min delay)
Last
4.4¢
Change
0.009(25.7%)
Mkt cap ! $52.53M
Open High Low Value Volume
3.6¢ 4.4¢ 3.6¢ $183.9K 4.656M

Buyers (Bids)

No. Vol. Price($)
1 1159 4.1¢
 

Sellers (Offers)

Price($) Vol. No.
4.4¢ 997342 3
View Market Depth
Last trade - 16.10pm 12/07/2024 (20 minute delay) ?
SNT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.